Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05070494Phase 4Unknown

Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients

Role: collaborator

NCT04122222Not ApplicableCompleted

Immune Response to Influenza Vaccine in ESRD Patients

Role: collaborator

NCT02194790Not ApplicableCompleted

Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.

Role: lead

NCT01978951Not ApplicableCompleted

Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand

Role: lead

All 4 trials loaded